Back to search results

Understanding Patient Engagement in Cancer Clinical Trials

This study aims to understand how patients learn about and engage with cancer clinical trials. It's an observational study, meaning you won't receive any new treatments; instead, researchers will gather information from you. The goal is to create better ways to help cancer patients get involved in clinical trials. You can join if you are 21 or older, of any gender, and have been diagnosed with any type of cancer. The study will measure changes in your understanding of clinical trials over a period of up to one year. This study is currently unclear on its recruitment status.

Study design
This is an observational study with a planned enrollment of 50 participants. It is not a treatment study, but rather focuses on gathering information.
What's involved
You will review educational materials and complete surveys throughout the study. This will last for up to one year.
Compensation
Not stated in the trial record.
Follow-up
You will be followed through study completion, which is up to one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07456436

Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials

Active, Not Recruiting
Not specifiedAges 21+Observational
University of Southern California
~111 participants
Updated 2026-08-18 on ClinicalTrials.gov
What's tested:Non-Interventional Study

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Baseline Survey Score
Measured over Through study completion, up to 1 year

Conditions

Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm

Explore related trials

Hematologic NeoplasmSolid Neoplasm

NCT07456436

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, Californiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Chanita Hughes-Halbert · PRINCIPAL_INVESTIGATOR · University of Southern California

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Eligible patient participants will be:
Black/African American, Asian/Asian American, White or Hispanic adults of any gender 21 years of age or older. Race/ethnicity will be self-reported
Have been diagnosed any cancer type

Exclusion

Participants (patients) will be excluded if they:
Are unable to give informed consent
Are unable to speak English or Spanish

What this trial measures

  • Change in Baseline Survey ScoreThrough study completion, up to 1 year

    The survey is a validated instrument (CHEKS\*) evaluated patients' knowledge and beliefs about cancer clinical trials (CCTs) before and after exposure to educational stimuli (written and video) detailing the purpose and characteristics of CCTs. The survey scores knowledge and beliefs about CCTs on a 100-point scale.The survey is collected before and after education materials are provided. The change in survey score will be analyzed. A paired t-test will be used to examine changes in CCT knowledge and Chi-Square tests of association to determine whether CCT knowledge and beliefs are associated with sociodemographic variables. \*Chung A, Donley T, Hays RD, et al. Development and evaluation of the Clinical Trial HEalth Knowledge and Beliefs Scale (CHEKS). Int J Environ Res Public Health. 2022;19(14):8660. doi:10.3390/ijerph19148660